Clinicopathological characteristics and survival outcomes of women aged ≤45 and >45 years with endometrial adenocarcinoma in tertiary referral hospital: a 21-year cohort study
Open Access
Abstract
Objective This study aimed to compare clinicopathological characteristics and oncological outcomes in patients with endometrial cancer aged ≤45 and >45 years, with a focus on identifying distinct traits and prognostic factors in younger patients. Design A retrospective cohort study. Setting The study was conducted at King Chulalongkorn Memorial Hospital, Bangkok, Thailand, with a restricted study population from 1996 to 2016. Participants A total of 1114 patients diagnosed with endometrial cancer and underwent surgery were strictly selected, excluding those who had received primary radiotherapy or had uterine sarcoma. Among the population, 188 patients (16.9%) were ≤45 years old and 926 patients (83.1%) were >45 years old. Outcome measures The primary outcome measures were disease-free survival (DFS) and overall survival (OS) at 5, 10 and 15 years, with an analysis of survival rates based on patient age groups and prognostic factors. Results Younger patients (≤45 years) displayed significantly higher rates of obesity, nulliparity and polycystic ovary syndrome (PCOS), as well as favourable pathological characteristics such as well-differentiated tumours and lower rates of myometrial invasion. They also exhibited better long-term survival outcomes, the DFS rates at 5, 10 and 15 years were 89.6% (95% CI: 84.0 to 98.3), 85.9% (95% CI: 79.0 to 90.6) and 76.8% (95% CI: 63.3 to 85.9), respectively, compared with 77.6% (95% CI: 74.6 to 80.2), 69.2% (95% CI: 65.6 to 72.5) and 53.5% (95% CI: 48.0 to 58.6) in the older group. Similarly, the OS rates at 5, 10 and 15 years were 94.7% (95% CI: 90.1 to 97.2), 91.7% (95% CI: 85.4 to 95.3) and 74.0% (95% CI: 51.7 to 87.2), respectively, compared with 86.9% (95% CI: 84.4 to 89.0), 76.6% (95% CI: 73.0 to 79.7) and 60.7% (95% CI: 55.0 to 65.8) in the older group. Independent prognostic factors consist of non-endometrioid histology, involvement of the lower uterine segment and cervix, omental metastasis, lymphovascular invasion and advanced stage. Conclusions Young patients with endometrial cancer exhibit distinct favourable clinicopathological characteristics associated with better oncological outcomes compared with older patients. However, certain aggressive disease features should be taken into consideration as they have a negative influence on prognosis significantly. These insights emphasise the need for targeted management strategies and further research.Keywords
This publication has 26 references indexed in Scilit:
- Ovarian conservation for young women with early-stage, low-grade endometrial cancer: a 2-step schemaAmerican Journal of Obstetrics and Gynecology, 2021
- Variations in incidence and mortality rates of endometrial cancer at the global, regional, and national levels, 1990–2019Gynecologic Oncology, 2021
- Malignant peritoneal cytology in endometrial cancer: Areas of unmet need for evidenceEuropean Journal of Cancer, 2020
- Risk factors for endometrial cancer: An umbrella review of the literatureInternational Journal of Cancer, 2018
- Updates on Conservative Management of Endometrial CancerJournal of Minimally Invasive Gynecology, 2018
- Endometrial cancerThe Lancet, 2016
- Clinical and pathological characterization of endometrial cancer in young women: Identification of a cohort without classical risk factorsGynecologic Oncology, 2015
- Recent changes in endometrial cancer trends among menopausal-age US womenCancer Epidemiology, 2013
- The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancerGynecologic Oncology, 2006
- Profile of women 45 years of age and younger with endometrial cancer*1Obstetrics & Gynecology, 1998